PSC vs UC and hepatobiliary cancer risk
How do PSC and UC compare in their association with hepatobiliary cancer risk, direct versus mediated effects
What is known
- The mediating (indirect) effect of PSC on UC-to-hepatobiliary-cancer was 0.083, representing 73.8% of the total effect, while the direct effect of UC was only 0.029 (total 0.113). 1
- Genetic susceptibility to PSC significantly increased hepatobiliary cancer risk (IVW OR 1.855), whereas UC showed no direct causal effect on hepatobiliary cancer. 1
- UC causally increased PSC risk (IVW OR 1.145) with no evidence of reverse causality, supporting a UC-to-PSC-to-cancer pathway. 1
- After PSC diagnosis the annual incidence of cholangiocarcinoma is about 1-2% with a 5-10% lifetime cumulative risk, and PSC patients also face elevated gallbladder cancer risk. 1,2
What is unknown / caveats
- Most cited hepatobiliary-cancer-specific causal evidence comes from a single Mendelian randomization study (PMID 39732896); other abstracts focus on colorectal rather than hepatobiliary neoplasia
- MR study used only European-descent GWAS data, limiting generalizability
- Subgroup analyses by sex, age, and comorbidity were constrained
- Several older abstracts address colorectal cancer risk, not hepatobiliary cancer, so cannot directly inform the direct-vs-mediated question
- Whether PSC acts as a complete versus partial mediator is not fully resolved, since a small non-significant direct UC effect remained.
References
- Wang F, Xiao J. The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization. Sci Rep. 2024. PMID: 39732896.
- Lee JW, Moon W. Are the risks of colorectal cancer and biliary cancer really increased if patients with ulcerative colitis have primary sclerosing cholangitis?. Intest Res. 2023. PMID: 37139591.
For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.
Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.
Sources retrieved: PMID 39732896 · PMID 18533354 · PMID 7590655 · PMID 21830268 · PMID 37139591 · PMID 10364038
answered 2026-08-04 · corpus build b46345ef · faithfulness 0.9655172413793104
Reviewer notes